InsidersTradesSigma
Follow the 成大生物 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 成大生物 has recorded 2 insider filings. Market capitalisation: €8.2bn. The latest transaction was reported on 11 April 2023 (Purchase). Among the most active insiders: 崔建伟. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
成大生物 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of biological and pharmaceutical products.